Tombot, Inc.

Robotic dog to help millions struggling daily with dementia, autism & depression

Print
Claim My Business
Security Type
Crowd SAFE
Min Investment
$249
Location
SANTA CLARITA, CA
Offering Date
September 07, 2022
Expected Close Date
March 24, 2023
Target Raise
$25.00K-$500.00K
No. Investors
261
Security Price
$1
Website
tombot.com
Number of Employees
5
Cash
$1,322,349
Revenue
$0
Short Term Debt
$4,001,244
Cost of Goods
$0
Long Term Debt
$49,889
Net Income
$1,967,693

Company Description

Research shows that interacting with a robotic animal reduces negative emotional and behavioral symptoms, improves social engagement, and promotes positive mood and quality of care experiences. This in turn reduces the need for psychotropic and pain medications.

Based on this knowledge, along with a deeply personal desire to revolutionize dementia care, we at Tombot set out to create a safe robotic animal companion for those with mental health adversities. Collaborating with Jim Henson’s Creature Shop (of Muppets and Dark Crystal fame) harnessed Hollywood magic to bring our invention to life.

Perks

Reserve
$249
Receive
Priority Waitlist (after Kickstarter & Front of the Line Passes)
Annual Investor Call

Reserve
$1,000
Receive
Front of the Waitlist Line Pass
Annual Investor Call

Reserve
$2,500
Receive
Front of the Waitlist Line Pass
Recognition on Tombot Investor Page
Exclusive Semi-Annual Investor Call & Q&A

Reserve
$5,000
Receive
Front of the Waitlist Line Pass
Recognition on Tombot Investor Page
Exclusive Semi-Annual Investor Call & Q&A
Exclusive Major Investor Newsletter

Reserve
$10,000
Receive
Front of the Waitlist Line
Recognition on Tombot Investor Page
Exclusive Semi-Annual Investor Call & Q&A
Exclusive Major Investor Newsletter
Dinner and Private Tour of Tombot Robotics Lab
Invitations to Tombot Major Investor Events

Key Deal Facts

Animatronic artistry by Jim Henson’s Creature Shop (creator of The Muppets)
Scientifically engineered to treat symptoms of mental illness
Aims to be the first robotic animal FDA device/health monitoring platform
A TIME Magazine “Best Invention” of 2020
$86.6B worldwide dementia TAM
2,500+ pre-order and waitlist customers
$4.6M already raised from investors

Perks

Reserve
$249
Receive
Priority Waitlist (after Kickstarter & Front of the Line Passes)
Annual Investor Call

Reserve
$1,000
Receive
Front of the Waitlist Line Pass
Annual Investor Call

Reserve
$2,500
Receive
Front of the Waitlist Line Pass
Recognition on Tombot Investor Page
Exclusive Semi-Annual Investor Call & Q&A

Reserve
$5,000
Receive
Front of the Waitlist Line Pass
Recognition on Tombot Investor Page
Exclusive Semi-Annual Investor Call & Q&A
Exclusive Major Investor Newsletter

Reserve
$10,000
Receive
Front of the Waitlist Line
Recognition on Tombot Investor Page
Exclusive Semi-Annual Investor Call & Q&A
Exclusive Major Investor Newsletter
Dinner and Private Tour of Tombot Robotics Lab
Invitations to Tombot Major Investor Events

Management Team / Advisory Board Bios

Tom Stevens
CEO & Founder

Hank Schorz
CTO

Jesse Schorz
COO
Amount Raised : $211,938
Reveal the Score by Voting
_
Not enough ratings to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

An equity crowdfunding specific version of a SAFE used by crowdfunding portal Republic. Upon conversion (if and when that happens), investors may receive special shares with limited rights that do not show up on a company’s cap table. The issuer may roll over and not convert shares at the next financing round causing investors to lose out on some upside.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments